| Name | Title | Contact Details |
|---|
MedVet is the leading veterinarian owned and led network of specialty and emergency hospitals dedicated to delivering exceptional care and a deeply supportive experience to pets and their loving families, referring veterinarians, and team members. For more than 35 years, MedVets empathetic, insightful, and driven team of expert caregivers has helped the organization grow to be the preferred choice for high quality, compassionate care, proudly serving more than 500,000 patients each year in communities throughout the United States. Our caregivers are deeply committed to MedVets mission of Leading Specialty Healthcare for Pets and our driven by our core values of Teamwork, Leadership, and Compassion. Visit www.medvet.com for further information and to view employment opportunities at MedVet. MedVet is an Equal Opportunity Employer.
Richelieu is Canadas leading distributor, importer, and manufacturer of specialty hardware and complementary products - and also ranks among the top players in its specialty in North America. We are the leading driver of worldwide innovations in functional and decorative hardware. We provide manufacturers and retailers with a UNIQUE mix of more than 130,000 different items in a host of categories: decorative hardware · kitchen accessories · lighting systems · functional and decorative mouldings · functional hardware · ergonomic workstations · finishing and decorating products · high-pressure laminates · veneer sheets and edgebanding products · screws and fasteners... We take pride in serving more than 110,000 customers across North America, in two major markets: * Manufacturers o Kitchen and bathroom cabinet manufacturers o Home and office furniture manufacturers o Residential and commercial woodworking industry, etc. * Retailers o Purchasing groups o Small and medium-sized hardware stores o Renovation superstores 113 distribution centers in North America. Some 3,000 people work throughout the network, more than half are specialized in sales and marketing, so as to provide our extensive base of loyal customers with first-class service. Richelieu Hardware Ltd. is a public company listed on the Toronto Stock Exchange (TSX) under the ticker symbol RCH.
Yokogawa Electric Corporation is a global leader in measurement, control, and information technologies. Founded in 1915 in Tokyo, Japan, the company began as a small laboratory focused on producing instruments that were primarily imported at the time. Today, Yokogawa operates in 60 countries and employs over 17,365 people, with a significant presence in North America. The company offers a diverse range of products and services, including measurement instruments, advanced control solutions for industrial automation, and information technologies for data management and analysis. Yokogawa serves various industries such as energy, chemicals, pharmaceuticals, and food, helping clients tackle complex production and operations management challenges. Their commitment to quality, innovation, and societal contribution guides their operations and partnerships with customers.
At OPTIMUM, an architecture, furniture, and technology (A/F/T) products collective, were not defined by size or the number of product lines but by our unique design-thinking approach. We believe in solving workplace challenges by optimizing the integration of architecture, furniture, and technology to create seamless experiences for those who design, plan, deliver, and occupy spaces. What sets us apart is our focus on offering aesthetically appealing, high-performance products that balance design and cost-efficiency, along with our partnerships with flexible manufacturers who can customize solutions to meet specific needs. Success isnt about individual pieces; its about the synergy that happens when people, elements, and solutions come together, resulting in outcomes far greater than the sum of their parts. This philosophy drives everything we do at OPTIMUM as we enhance the environments where we live, work, learn, and heal.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.